Bio Green Energy Tech PCL (BKK:BIOTEC)

Total Valuation

BKK:BIOTEC has a market cap or net worth of THB 519.07 million. The enterprise value is 1.25 billion.

Market Cap	519.07M
Enterprise Value	1.25B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BKK:BIOTEC has 3.05 billion shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	3.05B
Shares Outstanding	3.05B
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.84%
Owned by Institutions (%)	n/a
Float	1.06B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.12
PB Ratio	0.48
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.57, with an EV/FCF ratio of 6.74.

EV / Earnings	-11.96
EV / Sales	0.28
EV / EBITDA	12.57
EV / EBIT	n/a
EV / FCF	6.74

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.91.

Current Ratio	0.56
Quick Ratio	0.39
Debt / Equity	0.91
Debt / EBITDA	9.90
Debt / FCF	5.29
Interest Coverage	-0.08

Financial Efficiency

Return on equity (ROE) is -9.06% and return on invested capital (ROIC) is -0.13%.

Return on Equity (ROE)	-9.06%
Return on Assets (ROA)	-0.10%
Return on Invested Capital (ROIC)	-0.13%
Return on Capital Employed (ROCE)	-0.33%
Revenue Per Employee	22.12M
Profits Per Employee	-519,088
Employee Count	201
Asset Turnover	1.55
Inventory Turnover	20.86

Taxes

In the past 12 months, BKK:BIOTEC has paid 10.00 million in taxes.

Income Tax	10.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.04% in the last 52 weeks. The beta is 0.05, so BKK:BIOTEC's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-37.04%
50-Day Moving Average	0.19
200-Day Moving Average	0.24
Relative Strength Index (RSI)	39.90
Average Volume (20 Days)	485,556

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:BIOTEC had revenue of THB 4.45 billion and -104.34 million in losses. Loss per share was -0.03.

Revenue	4.45B
Gross Profit	129.93M
Operating Income	-4.66M
Pretax Income	-93.57M
Net Income	-104.34M
EBITDA	72.83M
EBIT	-4.66M
Loss Per Share	-0.03

Balance Sheet

The company has 256.71 million in cash and 979.21 million in debt, giving a net cash position of -722.49 million or -0.24 per share.

Cash & Cash Equivalents	256.71M
Total Debt	979.21M
Net Cash	-722.49M
Net Cash Per Share	-0.24
Equity (Book Value)	1.08B
Book Value Per Share	0.35
Working Capital	-572.91M

Cash Flow

In the last 12 months, operating cash flow was 211.04 million and capital expenditures -25.85 million, giving a free cash flow of 185.19 million.

Operating Cash Flow	211.04M
Capital Expenditures	-25.85M
Free Cash Flow	185.19M
FCF Per Share	0.06

Margins

Gross margin is 2.92%, with operating and profit margins of -0.10% and -2.33%.

Gross Margin	2.92%
Operating Margin	-0.10%
Pretax Margin	-2.10%
Profit Margin	-2.33%
EBITDA Margin	1.64%
EBIT Margin	-0.10%
FCF Margin	4.17%

Dividends & Yields

BKK:BIOTEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	n/a
Earnings Yield	-20.10%
FCF Yield	35.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:BIOTEC has an Altman Z-Score of 1.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.4
Piotroski F-Score	4